A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

ClinicalTrials.gov ID: NCT06672939

Public ClinicalTrials.gov record NCT06672939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 4:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Safety, and Pharmacokinetics of Orforglipron Once Daily Oral Versus Placebo in Adolescent Participants Who Have Obesity, or Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind Trial (ADVANCE-ATTAIN-ADOLESCENTS)

Study identification

NCT ID: NCT06672939
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 125 participants

Conditions and interventions

Conditions

Interventions

Orforglipron Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 17, 2024
Primary completion: Jan 31, 2027
Completion: Feb 28, 2027
Last update posted: Nov 4, 2025

2024 – 2027

United States locations

U.S. sites: 15
U.S. states: 12
U.S. cities: 14

Facility	City	State	ZIP	Site status
Carey Chronis MD Pediatric, Infant and Adolescent Medicine	Ventura	California	93003-5369	Recruiting
Yale School of Medicine - Yale Diabetes Center (YDC)) Trials	New Haven	Connecticut	06519	Not yet recruiting
Stamford Therapeutics Consortium	Stamford	Connecticut	06905	Recruiting
Children's Healthcare of Atlanta - Center for Advanced Pediatrics	Atlanta	Georgia	30329	Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
Velocity Clinical Research	Lafayette	Louisiana	70508	Recruiting
MedPharmics, LLC	Gulfport	Mississippi	39503-2637	Recruiting
Sundance Clinical Research	St Louis	Missouri	63141-7068	Recruiting
Lucas Research, Inc.	Morehead City	North Carolina	28557	Recruiting
Childrens Hospital of Pittsburgh	Pittsburgh	Pennsylvania	15224	Recruiting
Vanderbilt Health One Hundred Oaks	Nashville	Tennessee	37204	Not yet recruiting
Dynamed Clinical Research, LP d/b/a DM Clinical Research	Houston	Texas	77065	Recruiting
La Providence Pediatrics Clinic - Chemidox Clinical Trials	Houston	Texas	77071-1008	Recruiting
Martin Diagnostic Clinic	Tomball	Texas	77375-3332	Recruiting
Velocity Clinical Research, Salt Lake City	South Jordan	Utah	84088	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06672939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 4, 2025 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06672939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →